Preclinical & Clinical Exploration of ATR Inhibitors

Time: 10:00 am
day: Day One

Details:

  • Preclinical pharmacology profile of Merck ATR inhibitors (Berzosertib, M1774)
  • Preclinical exploration of options for mono- and combination therapy
  • Directions of clinical development for ATR inhibitors

Speakers: